Skip to content

Drug interactions

Lefamulin + Sorafenib

Severity: Moderate

Lefamulin and Sorafenib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lefamulin inhibits CYP3A4, but sorafenib is cleared mainly via CYP3A4 and UGT1A9, so the effect on exposure is likely modest. Both drugs can prolong the QT interval, which is the main concern.

What this interaction means in plain words

Lefamulin and Sorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lefamulin belongs to Anti Bacterial; Sorafenib belongs to Oncology.

Evidence level: Low

Why it happens

Additive QT prolongation, with a small contribution from CYP3A4 inhibition.

What to do

Obtain a baseline ECG, correct potassium and magnesium, and monitor QTc during co-treatment. Consider an alternative antibiotic in patients with existing QT risk.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lefamulin and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lefamulin with Sorafenib?

MediHelp rates the interaction as moderate. Lefamulin and Sorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lefamulin inhibits CYP3A4, but sorafenib is cleared mainly via CYP3A4 and UGT1A9, so the effect on exposure is likely modest. Both drugs can prolong the QT interval, which is the main concern.

How serious is the interaction between Lefamulin and Sorafenib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG, correct potassium and magnesium, and monitor QTc during co-treatment. Consider an alternative antibiotic in patients with existing QT risk.

What other medicines interact with Sorafenib?

MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in